Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 821

The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.

Translational control in cancer

Silvera, Deborah, Formenti, Silvia C., Schneider, Robert J. · 2010 · Nature Reviews Cancer

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrc2824

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. Pianese, G. Beitrag zur histologie und Aetiologie der carcinoma histologische und experimentelle. Beitr. Pathol. Anat. Allgem. Pathol. 142, 1–193 (1896).
  2. Mayeur, G. L. & Hershey, J. W. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514, 49–54 (2002). · doi:10.1016/s0014-5793(02)02307-4
  3. Zanelli, C. F. & Valentini, S. R. Is there a role for eIF5A in translation? Amino Acids 33, 351–358 (2007). · doi:10.1007/s00726-007-0533-0
  4. Jenkins, Z. A., Haag, P. G. & Johansson, H. E. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 71, 101–109 (2001). · doi:10.1006/geno.2000.6418
  5. Benne, R., Brown-Luedi, M. L. & Hershey, J. W. Purification and characterization of protein synthesis initiation factors eIF-1, eIF-4C, eIF-4D, and eIF-5 from rabbit reticulocytes. J. Biol. Chem. 253, 3070–3077 (1978). · doi:10.1016/s0021-9258(17)40804-0
  6. Kemper, W. M., Berry, K. W. & Merrick, W. C. Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Bα and M2Bβ. J. Biol. Chem. 251, 5551–5557 (1976). · doi:10.1016/s0021-9258(17)33095-8
  7. Hanauske-Abel, H. M. et al. Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett. 366, 92–98 (1995). · doi:10.1016/0014-5793(95)00493-s
  8. Cracchiolo, B. M. et al. Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol. Oncol. 94, 217–222 (2004). · doi:10.1016/j.ygyno.2004.03.018
  9. Rosso, P. et al. Overexpression of p27BBP in head and neck carcinomas and their lymph node metastases. Head Neck 26, 408–417 (2004). · doi:10.1002/hed.10401
  10. Rosenwald, I. B., Hutzler, M. J., Wang, S., Savas, L. & Fraire, A. E. Expression of eukaryotic translation initiation factors 4E and 2α is increased frequently in bronchioloalveolar but not in squamous cell carcinomas of the lung. Cancer 92, 2164–2171 (2001). · doi:10.1002/1097-0142(20011015)92:8<2164::aid-cncr1559>3.0.co;2-a
  11. Haines, G. K. et al. Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 63, 289–295 (1993). · doi:10.1007/bf02899275
  12. Rosenwald, I. B., Wang, S., Savas, L., Woda, B. & Pullman, J. Expression of translation initiation factor eIF-2α is increased in benign and malignant melanocytic and colonic epithelial neoplasms. Cancer 98, 1080–1088 (2003). · doi:10.1002/cncr.11619
  13. Wang, S. et al. Expression of the eukaryotic translation initiation factors 4E and 2α in non-Hodgkin's lymphomas. Am. J. Pathol. 155, 247–255 (1999). · doi:10.1016/s0002-9440(10)65118-8
  14. Rosenwald, I. B. et al. Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum. Pathol. 39, 910–916 (2008). · doi:10.1016/j.humpath.2007.10.021
  15. Bachmann, F., Banziger, R. & Burger, M. M. Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res. 57, 988–994 (1997).
  16. Dellas, A. et al. Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83, 1376–1383 (1998). · doi:10.1002/(sici)1097-0142(19981001)83:7<1376::aid-cncr15>3.0.co;2-1
  17. Pincheira, R., Chen, Q. & Zhang, J. T. Identification of a 170-kDa protein over-expressed in lung cancers. Br. J. Cancer 84, 1520–1527 (2001). · doi:10.1054/bjoc.2001.1828
  18. Chen, G. & Burger, M. M. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation. Int. J. Cancer 112, 393–398 (2004). · doi:10.1002/ijc.20443
  19. Rothe, M., Ko, Y., Albers, P. & Wernert, N. Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am. J. Pathol. 157, 1597–1604 (2000). · doi:10.1016/s0002-9440(10)64797-9
  20. Guan, X. Y. et al. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 61, 3806–3809 (2001).
  21. Xie, D. et al. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum. Pathol. 39, 80–86 (2008). · doi:10.1016/j.humpath.2007.05.011
  22. Luo, J. H. et al. Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder. Cancer Sci. 100, 896–902 (2009). · doi:10.1111/j.1349-7006.2009.01126.x
  23. Chen, W. et al. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol. Biomarkers Prev. 18, 400–408 (2009). · doi:10.1158/1055-9965.epi-08-0754

Cited by

See all 821

Metadata

Authors
Silvera, D., Formenti, S. C., & Schneider, R. J.
Venue
Nature Reviews Cancer
Published
2010-04
Volume
10
Issue
4
Pages
254-266
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2089716875
Cited by
821
References
125
FWCI
3.45
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.